Blood Irradiation Market Analysis and Forecast to 2031: By Type (Intravenous Laser Blood Irradiation, Transcutaneous Laser Blood Irradiation, Extracorporeal Blood Irradiation), Indication (Acute Leukemia, Lymphoma, Solid Tumors, Pelvic Tumors, Others), En

Blood Irradiation Market Analysis and Forecast to 2031: By Type (Intravenous Laser Blood Irradiation, Transcutaneous Laser Blood Irradiation, Extracorporeal Blood Irradiation), Indication (Acute Leukemia, Lymphoma, Solid Tumors, Pelvic Tumors, Others), End User (Hospitals, Blood Banks, Diagnostic Clinics, Research Institutes), and Region

The global blood irradiation market was valued at USD 66.0 million in 2021 and it is anticipated to grow further till USD 128.1 million in 2031, at a CAGR of 6.9% during the forecast period.

To stop the proliferation of specific types of T cells, blood components are radioactively treated before being transfused. Due to white blood cell transfusion generated by these T lymphocytes, a rare condition known as graft-versus-host disease (GVHD) with serious complications might occur. A small number of white blood cells have the ability to identify the various blood types in the body that can result in fatal sickness or serious illness. UV, X-rays, and other radioactive techniques are used to cure radioactively contaminated blood. Patients with cancer benefit from blood irradiation treated with UV rays because it boosts the immune system and enhances general health.

Market Trends and Drivers

The growth of the global blood irradiation market is anticipated to be fueled by an increasing number of people who are susceptible to various communicable and non-communicable diseases (NCDs), including cancer, chronic renal disease, high blood pressure, stroke, and cardiovascular disorders. For instance, the World Bank's 2016 report estimates that there were 7.44 billion people on the planet. In 2018, the World Health Organization (WHO) reported that non-communicable illnesses were responsible for around 41 million deaths worldwide, or 71% of all fatalities. Additionally, 17.9 million deaths each year are caused by cardiovascular illnesses, which are followed by diabetes (1.6 million), other respiratory diseases (3.9 million), and cancer (9.0 million) in that order. The rising incidence of non-communicable diseases increases consumer desire for faster blood stream treatment, which is anticipated to significantly fuel market expansion for blood irradiation.

Market Restraints and Challenges

The development of the worldwide blood irradiation market is expected to be constrained by medical system regulation legislation and a shortage of qualified specialists in developing economies. Problems and difficulties associated with blood component irradiation include delayed transfusions, high costs, failure to irradiate, when necessary, increased potassium accumulation in and shortened shelf life of RBC units, and decreased RBC recovery.

Global Blood Irradiation Market Segmental Overview

The report analyses the global blood irradiation market based on the type, indication, end user, and region.

Global Blood Irradiation Market by Type

Based on the type, it is segmented into intravenous laser blood irradiation, transcutaneous laser blood irradiation, and extracorporeal blood irradiation. The intravenous laser blood irradiation segment accounted for the majority of the market share. However, the extracorporeal laser blood irradiation segment is anticipated to grow at the highest CAGR during the forecast period.

Global Blood Irradiation Market by Indication

Based on the indication, it is segmented into acute leukemia, solid tumors, pelvic tumors, lymphoma, and others. The acute leukemia segment is expected to dominate the market during the forecast period. Likewise, the lymphoma segment is likely to grow at the fastest CAGR during the forecast period.

Global Blood Irradiation Market by End User

Based on the end user, it is segmented into hospitals, blood banks, diagnostic clinics, and research institutes. The hospital segment is likely to dominate the market during the forecast period. Similarly, the blood banks segment is anticipated to register the highest CAGR during the forecast period.

Geographical Analysis of the Global Blood Irradiation Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America region is expected to hold a dominant position during the forecast period. Owing to growing awareness among the population regarding blood-related diseases and the launch of new innovative technology in the field of healthcare.

Major Players in the Global Blood Irradiation Market

The key players studied in the report are

COVID-19 Impact

The COVID-19 epidemic produced by the SARS-CoV-2 coronavirus has had a substantial impact on healthcare systems around the world. The cytokine storm that accompanies lung infection is causally linked to respiratory impairment and mortality in the majority of patients. Governments all over the world instituted lockdowns and restrictions to stop the spread of Covid-19. Global value chains, as well as capabilities for dissemination and coordination, have been significantly impacted by this. Additionally, a number of end-client businesses have suffered significant financial losses as a result of their waning popularity. Anyhow, vaccination will significantly contribute to controlling and managing worldwide pandemics.

Several viral illnesses, including SARS-CoV-2, MERS, HIV/AIDS, Ebola, and SARS, have emerged recently. Brought back to the fore this healing opportunity. Blood irradiation, or BI, has a variety of virucidal effects, but its main immune system-related effects Hematological malignancies are also treated by a more complex process called extracorporeal photopheresis (ECP). For instance, T-cell lymphomas. Additional study into BI might result in the creation of a useful tool that could be used to battle new viruses that are immune to vaccines or known antivirals, as well as bacteria that are resistant to antibiotics. The result is in spite of the pandemic, the market is growing moderately.

Recent Developments

• June 2021, Rad Sources Technolgies, a commercial X-ray radiation production supplier in the US, designed a product to replace self-shielded gamma irradiators and introduced its newly redesigned RS 3400 Blood Irradiator at MEDLAB Middle East 2021.
• November 2018, JW Bioscience Co. Ltd., a south Korean medical device business, unveiled ‘Sangray’, a blood radiation device.
• September 2017, Typenex Medical launched Rad-Control, a new irradiation tag technology for blood centers and blood banks in Canada and the U.S. This checkss blood irradiation by visual verification, minimizes current documentation practices, and increases efficiency for healthcare staff.

Frequently Asked QuestionsQ1. How big is the Blood Irradiation market?Ans. The global Blood Irradiation market size was USD 66.0 million in 2021 and is anticipated to reach USD 128.1 million in 2031, growing at a rate of 6.9% from 2022 to 2031.Q2. What is the Blood Irradiation market growth rate?Ans. The growth rate of the Blood Irradiation market is 6.9%.Q3. Which region holds a major market share for the Blood Irradiation market?Ans. North America holds a major market share of the Blood Irradiation market in 2021.Q4. Which segment accounted for the largest Blood Irradiation market share?Ans. By indication, the acute leukemia segment accounted for the largest Blood Irradiation market share.Q5. Who are the key players in the Blood Irradiation market?Ans. The global Blood Irradiation market report includes players such as Q6. What are the factors driving the Blood Irradiation market growth?Ans. The major factors driving the growth of the market are the growing healthcare market in emerging countries.Q7. What are the key growth strategies of Blood Irradiation market players?Ans. The key growth strategies of Blood Irradiation market players are product launch and product approval.Q8. Which region will provide more business opportunities for the Blood Irradiation market during the forecast period?Ans. The Asia-Pacific region will provide more business opportunities for the Blood Irradiation market during the forecast period.

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.